MTOR and cancer: Besides, our data showed that ADORA1 could activate EMT, Hormone ER, PI3K/AKT, RAS/MAPK, TSC/mTOR pathways and inhibit RTK, Hormone AR, DNA Damage Response, Cell Cycle, Apoptosis pathways to exert regulatory effects on the cancer process.